Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
Parker, EP
; Desai, S; Marti, M; O'Brien, KL; Kaslow, DC; Kochhar, S; Olayinka, F; Cravioto, A; Nohynek, H; Hombach, J; +1 more...Wilder-Smith, A and
(2022)
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
The Lancet Infectious Diseases, 22 (4).
pp. 438-440.
ISSN 1473-3099
DOI: 10.1016/S1473-3099(22)00178-5
; Desai, S; Marti, M; O'Brien, KL; Kaslow, DC; Kochhar, S; Olayinka, F; Cravioto, A; Nohynek, H; Hombach, J; +1 more...Wilder-Smith, A and
(2022)
Emerging evidence on heterologous COVID-19 vaccine schedules-To mix or not to mix?
The Lancet Infectious Diseases, 22 (4).
pp. 438-440.
ISSN 1473-3099
DOI: 10.1016/S1473-3099(22)00178-5
-
picture_as_pdf - Parker_etal_2022_To-mix-or-not-to.pdf
-
subject - Accepted Version
-
error - This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0
Downloads